IS1364B6 - Aðferð til að búa til og nota, með nýju fyrirkomulagi, súlpíríd sem má gleypa, þannig að það inniheldur staðlað magn af lífrænum efnum, sem finnast ínáttúrunni - Google Patents

Aðferð til að búa til og nota, með nýju fyrirkomulagi, súlpíríd sem má gleypa, þannig að það inniheldur staðlað magn af lífrænum efnum, sem finnast ínáttúrunni

Info

Publication number
IS1364B6
IS1364B6 IS2900A IS2900A IS1364B6 IS 1364 B6 IS1364 B6 IS 1364B6 IS 2900 A IS2900 A IS 2900A IS 2900 A IS2900 A IS 2900A IS 1364 B6 IS1364 B6 IS 1364B6
Authority
IS
Iceland
Prior art keywords
sulfiride
absorbable
nature
making
under
Prior art date
Application number
IS2900A
Other languages
English (en)
Other versions
IS2900A7 (is
Inventor
Pitel Guy
Original Assignee
Société d'études Scientifiques et Industrielles de l'Ile-de-France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Société d'études Scientifiques et Industrielles de l'Ile-de-France filed Critical Société d'études Scientifiques et Industrielles de l'Ile-de-France
Publication of IS2900A7 publication Critical patent/IS2900A7/is
Publication of IS1364B6 publication Critical patent/IS1364B6/is

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IS2900A 1983-12-23 1984-03-30 Aðferð til að búa til og nota, með nýju fyrirkomulagi, súlpíríd sem má gleypa, þannig að það inniheldur staðlað magn af lífrænum efnum, sem finnast ínáttúrunni IS1364B6 (is)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8320635A FR2556964A1 (fr) 1983-12-23 1983-12-23 Nouvelles formes galeniques du sulpiride utilisables par voie orale

Publications (2)

Publication Number Publication Date
IS2900A7 IS2900A7 (is) 1984-11-14
IS1364B6 true IS1364B6 (is) 1989-05-25

Family

ID=9295477

Family Applications (1)

Application Number Title Priority Date Filing Date
IS2900A IS1364B6 (is) 1983-12-23 1984-03-30 Aðferð til að búa til og nota, með nýju fyrirkomulagi, súlpíríd sem má gleypa, þannig að það inniheldur staðlað magn af lífrænum efnum, sem finnast ínáttúrunni

Country Status (38)

Country Link
EP (1) EP0147244A1 (is)
JP (1) JPS60139616A (is)
KR (1) KR910004570B1 (is)
AR (1) AR231398A1 (is)
AU (1) AU569516B2 (is)
BE (1) BE899331A (is)
BG (1) BG49707A3 (is)
CH (1) CH659386A5 (is)
CZ (1) CZ262984A3 (is)
DD (1) DD220782A5 (is)
DE (1) DE3412868A1 (is)
DK (1) DK165729C (is)
ES (1) ES532125A0 (is)
FI (1) FI82603C (is)
FR (1) FR2556964A1 (is)
GB (1) GB2151920B (is)
GR (1) GR79584B (is)
HU (1) HU190924B (is)
IE (1) IE57164B1 (is)
IL (1) IL71470A (is)
IN (1) IN160415B (is)
IS (1) IS1364B6 (is)
IT (1) IT1177655B (is)
LU (1) LU85290A1 (is)
MA (1) MA20088A1 (is)
MX (1) MX7715E (is)
NO (1) NO169575C (is)
NZ (1) NZ207753A (is)
OA (1) OA07700A (is)
PH (1) PH21938A (is)
PL (1) PL144356B1 (is)
PT (1) PT78382B (is)
RO (1) RO89437A (is)
SU (1) SU1478993A3 (is)
YU (1) YU44762B (is)
ZA (1) ZA842573B (is)
ZM (1) ZM2084A1 (is)
ZW (1) ZW6084A1 (is)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8414220D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Medicaments in unit dose form
EP0212746B1 (en) * 1985-08-16 1991-04-10 The Procter & Gamble Company Drug particles having constant release
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
JPH0791184B2 (ja) * 1988-03-31 1995-10-04 田辺製薬株式会社 放出制御型製剤およびその製法
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
FR2453642A1 (fr) * 1979-04-12 1980-11-07 Sanofi Sa Compositions therapeutiques a usage oral et a liberation programmee du methanesulfonate de dihydroergotoxine
FR2454804B1 (fr) * 1979-04-26 1986-11-21 Sanofi Sa Medicament a base de dihydroergotoxine et son procede de preparation
FR2470599A1 (fr) * 1979-12-07 1981-06-12 Panoz Donald Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
JPS5753326A (en) * 1980-09-17 1982-03-30 Dainippon Printing Co Ltd Manufacture of biaxially stretching blow molded vessel of saturated polyester
FR2492661A1 (fr) * 1980-10-28 1982-04-30 Laruelle Claude Nouvelle forme galenique d'administration du metoclopramide, son procede de preparation et medicament comprenant cette nouvelle forme
FR2494112B1 (is) * 1980-11-19 1986-01-10 Laruelle Claude
FR2534139B1 (fr) * 1982-10-07 1986-08-29 Laruelle Claude Nouvelle forme galenique du sulpiride, son procede de preparation et medicament comprenant cette nouvelle forme

Also Published As

Publication number Publication date
DK180784A (da) 1985-06-24
YU64084A (en) 1988-02-29
BE899331A (fr) 1984-10-05
PT78382B (fr) 1986-05-28
IT1177655B (it) 1987-08-26
IL71470A0 (en) 1984-07-31
NO169575B (no) 1992-04-06
FR2556964A1 (fr) 1985-06-28
JPS60139616A (ja) 1985-07-24
MA20088A1 (fr) 1984-12-31
YU44762B (en) 1991-02-28
LU85290A1 (fr) 1984-10-26
ZA842573B (en) 1984-11-28
DE3412868A1 (de) 1985-07-11
GB2151920A (en) 1985-07-31
IE840817L (en) 1985-06-23
JPH0461848B2 (is) 1992-10-02
DD220782A5 (de) 1985-04-10
DK165729C (da) 1993-06-07
KR850005065A (ko) 1985-08-21
GB2151920B (en) 1987-09-23
IT8448001A0 (it) 1984-04-06
GB8408978D0 (en) 1984-05-16
FI841376A0 (fi) 1984-04-06
DK180784D0 (da) 1984-04-06
RO89437A (ro) 1986-06-30
BG49707A3 (en) 1992-01-15
ZW6084A1 (en) 1984-08-08
HU190924B (en) 1986-12-28
EP0147244A1 (fr) 1985-07-03
ES8502332A1 (es) 1985-01-01
NO841367L (no) 1985-06-24
GR79584B (is) 1984-10-30
PL144356B1 (en) 1988-05-31
KR910004570B1 (ko) 1991-07-06
HUT35518A (en) 1985-07-29
DK165729B (da) 1993-01-11
PH21938A (en) 1988-04-15
NO169575C (no) 1992-07-15
FI82603C (fi) 1991-04-10
ZM2084A1 (en) 1984-12-21
AU569516B2 (en) 1988-02-04
PT78382A (fr) 1984-05-01
OA07700A (fr) 1985-08-30
ES532125A0 (es) 1985-01-01
IL71470A (en) 1987-07-31
MX7715E (es) 1990-10-09
FI841376A (fi) 1985-06-24
IS2900A7 (is) 1984-11-14
FI82603B (fi) 1990-12-31
AU2890484A (en) 1985-06-27
IT8448001A1 (it) 1985-10-06
NZ207753A (en) 1987-08-31
PL247098A1 (en) 1985-07-02
CZ262984A3 (en) 1995-07-12
SU1478993A3 (ru) 1989-05-07
CH659386A5 (fr) 1987-01-30
IN160415B (is) 1987-07-11
AR231398A1 (es) 1984-11-30
IE57164B1 (en) 1992-05-20

Similar Documents

Publication Publication Date Title
MX161033A (es) Mejoras en sellos de lengueta y su metodo de fabricacion
MX160020A (es) Mejoras en aparato electronico estimulador para salivacion
DE3677364D1 (de) Markierte makromolekuele; verfahren zu ihrer herstellung und ihre verwendung in immunologischen oder immunocytochemischen testen.
DK162817C (da) Apparat til hypertermi, og endotraktelektrode til anvendelse i apparatet
NO165279C (no) Fremgangsmaate og apparat for aa separere komponentene i enborebroennstroem.
KR890700983A (ko) 디지틸 변조방법 및 장치
DE3581708D1 (de) Selektive zusammensetzungen zum abziehen von nickel sowie abziehverfahren.
GB2154608B (en) Method and device for performing microoperations on cells
DK648187D0 (da) Fremgangsmaade og apparat til fremstilling af kredsloebsdel
DK300589A (da) Fremgangsmaade og apparat til fremstilling af lynlaase
DK25983D0 (da) Apparat til opbevaring, udtraekning og afskaering af baneformede materialer i oenskede laengder
IS1364B6 (is) Aðferð til að búa til og nota, með nýju fyrirkomulagi, súlpíríd sem má gleypa, þannig að það inniheldur staðlað magn af lífrænum efnum, sem finnast ínáttúrunni
DE59009864D1 (de) Verfahren und Schaltung zur Auswertung von kontinuierlich auftretenden Zeitmarken.
DK241790D0 (da) Fremgangsmaade til fremstilling af sucralfat og aai-10001
IT8467200A1 (it) Metodo e apparecchio per posizionare isolatori intermedi in nuclei.
DE69124072T2 (de) Supraleitende Schaltung und Verfahren zu ihrer Herstellung
DK39689A (da) Fremgangsmaade til fremstilling af n-phosphonmethyliminodieddikesyre og n-phosphonmethyliminodieddikesyrechlorid
DE3468776D1 (en) Polarized electronic component, and method for its manufacture
DE3782334T2 (de) Materialmagnetisierungsmethode und -vorrichtung.
DK153117C (da) Fremgangsmaade og maskine til fremstilling af kugleformede kartofler
DK443487A (da) Multistik og fremgangsmaade og maskine til fremstilling af samme
DK422181A (da) Bad og fremgangsmaade til hoejhastigheds-nikkelelektroplettering
DK394183D0 (da) Spindeltrappe og afstandselement til anvendelse i en sadan
KR880700322A (ko) 석판화 기술을 이용한 장치 및 그 제조 방법
DK382284D0 (da) Fremgangsmaade til fremstilling af 7-acylamino-3-hydroxy-cephem-4-carbxylsyrer og 7-acylamino-3-hydroxy-1-dethia-1-oxacephem-4-carboxylsrer